Related Experiment Video
Updated: Jan 13, 2026

10:25
Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
9.9K
Circulating CD34 Positive Cells and Immunological Responses in Extremely Preterm Infants
Ulrika Sjöbom1,2, Helena Barreto Henriksson2,3,4, Anders K Nilsson2
1Learning and Leadership for Health Care Professionals, Institute of Health and Care Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Journal of Blood Medicine
|October 28, 2025
Summary
Monitoring hematopoietic stem and progenitor cells (CD34+) in preterm infants is feasible using residual blood. CD34+ cell counts showed high variability and correlated with infections, offering insights into early immune function.
Area of Science:
- Neonatal Hematology
- Immunology
- Developmental Biology
Background:
- Preterm birth can disrupt fetal hematopoietic system development.
- Hematopoietic stem and progenitor cell (CD34+) dynamics in preterm infants are understudied due to limited blood volumes.
- Residual blood samples offer a viable alternative for studying CD34+ cells in this population.
Purpose of the Study:
- To characterize the dynamics of circulating CD34+ cells in extremely preterm infants.
- To explore associations between CD34+ cell counts and prenatal/postnatal clinical events.
- To assess the feasibility of using residual clinical blood for longitudinal monitoring.
Main Methods:
- Longitudinal analysis of residual blood samples from nine infants born <28 weeks gestational age.
- Flow cytometry assessment of CD34+ cell counts.
- Measurement of nucleated red/white blood cells and hemoglobin concentration.
Main Results:
- Observed high inter- and intra-individual variability in CD34+ cell counts.
- CD34+ cell proportion decreased significantly by day 7 post-birth.
- Elevated CD34+ cell levels were associated with maternal or infant infections.
Conclusions:
- Longitudinal monitoring of CD34+ cells in extremely preterm infants is feasible using residual blood.
- Preliminary data suggest links between CD34+ cell dynamics and early-life infections.
- Further research in larger cohorts is warranted to confirm findings and explore immune function.

